Pharvaris N.V.

Related Filers (13)

Other (78)

6-K
Friday, 2/16/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Thursday, 2/15/2024
Filing for proposed sale of securities under Rule 144
6-K
Wednesday, 2/7/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Thursday, 2/1/2024
Filing for proposed sale of securities under Rule 144
6-K
Monday, 1/22/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/8/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Tuesday, 1/2/2024
Filing for proposed sale of securities under Rule 144
6-K
Friday, 12/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144
Wednesday, 12/6/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 11/17/2023
Filing for proposed sale of securities under Rule 144
6-K
Thursday, 11/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
144/A
Wednesday, 9/20/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 9/19/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 9/1/2023
Filing for proposed sale of securities under Rule 144
EFFECT
Wednesday, 8/16/2023
Notice of Effectiveness
CORRESP
Tuesday, 8/15/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
144
Wednesday, 8/9/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/9/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/9/2023
Filing for proposed sale of securities under Rule 144
6-K
Monday, 8/7/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Monday, 8/7/2023
Registration statement for specified transactions by certain foreign private issuers
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 4/5/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 4/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/12/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Tuesday, 7/5/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 3/29/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 3/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 3/10/2022
Notice of Effectiveness
CORRESP
Tuesday, 3/8/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Wednesday, 3/2/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Monday, 1/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/7/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/10/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/30/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/1/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/29/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/11/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/12/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Monday, 5/3/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 4/29/2021
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 4/29/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SEC STAFF LETTER
Thursday, 2/4/2021
None
CERT
Thursday, 2/4/2021
Certification by an exchange approving securities for listing
F-1MEF
Thursday, 2/4/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form F-1
8-A12B
Thursday, 2/4/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
EFFECT
Thursday, 2/4/2021
Notice of Effectiveness
CORRESP
Tuesday, 2/2/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 2/2/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 2/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Monday, 2/1/2021
Registration statement for securities of certain foreign private issuers
CORRESP
Friday, 1/22/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 1/22/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Friday, 1/22/2021
Registration statement for securities of certain foreign private issuers
F-1
Friday, 1/15/2021
Registration statement for securities of certain foreign private issuers
SEC STAFF LETTER
Tuesday, 1/12/2021
None
Show More

Ownership (25)

SC 13G/A
Wednesday, 2/14/2024
VIKING GLOBAL INVESTORS LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Venrock Healthcare Capital Partners III, L.P.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
GENERAL ATLANTIC, L.P.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Foresite Capital Fund IV, L.P.: Major Shareholders
SC 13G/A
Friday, 2/9/2024
FMR LLC: Major Shareholders
SC 13G/A
Thursday, 2/8/2024
LSP V Cooperatieve U.A.: Major Shareholders
SC 13D/A
Thursday, 1/25/2024
venBio Global Strategic Fund III, L.P.: Major Shareholders
SC 13G/A
Monday, 1/22/2024
Bain Capital Life Sciences Fund, L.P.: Major Shareholders
SC 13G
Thursday, 11/30/2023
Venrock Healthcare Capital Partners III, L.P.: Major Shareholders
SC 13G/A
Friday, 6/23/2023
Bain Capital Life Sciences Fund, L.P.: Major Shareholders
SC 13G/A
Friday, 6/23/2023
GENERAL ATLANTIC, L.P.: Major Shareholders
SC 13D/A
Wednesday, 6/21/2023
venBio Global Strategic Fund III, L.P.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
VIKING GLOBAL INVESTORS LP: Major Shareholders
SC 13G/A
Monday, 2/13/2023
Foresite Capital Fund IV, L.P.: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
FMR LLC: Major Shareholders
SC 13D/A
Monday, 9/26/2022
venBio Global Strategic Fund III, L.P.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
VIKING GLOBAL INVESTORS LP: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Foresite Capital Fund IV, L.P.: Major Shareholders
SC 13G
Wednesday, 2/9/2022
FMR LLC: Major Shareholders
SC 13G
Thursday, 2/3/2022
LSP V Cooperatieve U.A.: Major Shareholders
SC 13G
Friday, 2/19/2021
GENERAL ATLANTIC LLC: Major Shareholders
SC 13G
Friday, 2/19/2021
Bain Capital Life Sciences Fund, L.P.: Major Shareholders
SC 13D
Friday, 2/19/2021
venBio Global Strategic Fund III, L.P.: Major Shareholders
SC 13G
Tuesday, 2/16/2021
VIKING GLOBAL INVESTORS LP: Major Shareholders
SC 13G
Friday, 2/12/2021
Foresite Capital Fund IV, L.P.: Major Shareholders
Show More